CompaniesCynvenio Biosystems

Cynvenio Biosystems

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

5,500

By Status

UNKNOWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT00578240
NCT02639832
Hover over trial bars to see details

Recent Trials

NCT02639832Lead Sponsor
A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.
N/AUnknown
210 participants
Started: Dec 31, 2015
NCT00578240Collaborator
Molecular Studies and Clinical Correlations in Human Prostatic Disease
N/AActive, not recruiting
5,290 participants
Started: Apr 30, 1990 · Completed: Dec 31, 2026
Funding History (10)
D
Mar 22, 2024
Filing
D
Jul 16, 2021
Filing
D
Jul 16, 2021
Filing
D
Jul 15, 2021
Filing
D/A
May 26, 2021
Filing
D
Dec 7, 2020
Filing
D/A
Mar 19, 2020
Filing
D/A
Oct 29, 2019
Filing
D/A
Sep 5, 2019
Filing
D/A
Apr 1, 2019
Filing